"We want to enrich further our API production expertise and the University of Warsaw has excellent competencies in the area of chemical and biological processes engineering."
In Conversation
"One of NICE’s hallmarks is that that we have always been prepared to explain our reasoning and evaluation process to patients, companies and the public, usually…
"Ecuador is a target country for pharmaceutical companies, notably because the country’s dollarized economy is a protection the economic variations one can witness in other Latin…
"What IQ does is what we ask our customers to do: innovate, digitize, be ready for disruptor technology and futureproof oneself."
"It took a long time for the three Baltic states to cooperate because of differences in legislation but now we are proud to have two different…
"I think the public drug plans that we support and represent would agree that prudent financial investment in pharmaceuticals are amongst our biggest challenges."
"Last year, our cancer awareness action reached over 200,000 Ecuadorians, and nurses delivering leaflets about the risk-increasing factors of cancers ensured the continuity with Roche’s work…
"We advocate with facts: we show what the potential costs are, we use academics' past achievements in Canada, and we show how advances and progress made…
"Poland is a price-based market and companies must understand this aspect when entering."
The most important thing is to develop and make accessible breakthrough therapies that provide significant value
"Janssen is very eager to sit down with the authorities, payers and healthcare providers to establish an agreed framework where the value of our overall contribution…
"In the expectation of legalization, Organigram has been working in close collaboration with the federal government and even more intensively with some of the provincial governments."
